News
Dislocation following hip replacements has declined over time and has modifiable risk factors
Dislocation following primary total hip replacements has declined over time, and has a number of modifiable risk factors, research from the NIHR Bristol Biomedical Research Centre and published in The Lancet Rheumatology has found. Dislocation following total hip replacement is associated with repeated admissions to hospital and substantial costs…
Risk of bias in evidence underpinning approval of new cancer drugs raises questions
Around half of trials that supported new cancer drug approvals in Europe between 2014 and 2016 were judged to be at high risk of bias, a study published by the British Medical Journal (BMJ) has found. The research was led by the London School of Economics, with methodological…
Joint replacement research shortlisted for ONS Research Excellence Award
Joint replacement research from the NIHR Bristol Biomedical Research Centre (BRC) is one of only four projects shortlisted for the Office for National Statistics (ONS) Research Excellence Award 2019. The award recognises and celebrate outstanding innovative research carried out using ONS data, or data the ONS makes available on…